Resources
É«¿Ø´«Ã½ Comment Letter on Interchangeable Biosimilar Applications
Comment Letter
É«¿Ø´«Ã½ submitted comments to FDA Commissioner Robert M. Califf, M.D., regarding interchangeable biosimilar applications.
Document Info
Published on Aug 20, 2024
Download and read the full Resource.